ATE540981T1 - Lösliche fusionsproteine enthaltend heterologe polypeptide - Google Patents
Lösliche fusionsproteine enthaltend heterologe polypeptideInfo
- Publication number
- ATE540981T1 ATE540981T1 AT05770112T AT05770112T ATE540981T1 AT E540981 T1 ATE540981 T1 AT E540981T1 AT 05770112 T AT05770112 T AT 05770112T AT 05770112 T AT05770112 T AT 05770112T AT E540981 T1 ATE540981 T1 AT E540981T1
- Authority
- AT
- Austria
- Prior art keywords
- soluble fusion
- heterologue
- polypeptides
- fusion proteins
- soluble
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60036304P | 2004-08-11 | 2004-08-11 | |
PCT/IL2005/000874 WO2006016370A2 (en) | 2004-08-11 | 2005-08-11 | Soluble fusion proteins comprising heterologous polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE540981T1 true ATE540981T1 (de) | 2012-01-15 |
Family
ID=35229843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05770112T ATE540981T1 (de) | 2004-08-11 | 2005-08-11 | Lösliche fusionsproteine enthaltend heterologe polypeptide |
Country Status (4)
Country | Link |
---|---|
US (2) | US7560250B2 (de) |
EP (1) | EP1778729B1 (de) |
AT (1) | ATE540981T1 (de) |
WO (1) | WO2006016370A2 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006016370A2 (en) | 2004-08-11 | 2006-02-16 | Ramot At Tel Aviv University Ltd. | Soluble fusion proteins comprising heterologous polypeptides |
CN105468895A (zh) | 2006-05-02 | 2016-04-06 | 普罗透斯数字保健公司 | 患者定制的治疗方案 |
EP2083680B1 (de) | 2006-10-25 | 2016-08-10 | Proteus Digital Health, Inc. | Einnehmbarer identifikator mit kontrollierer aktivierung |
EP2069004A4 (de) | 2006-11-20 | 2014-07-09 | Proteus Digital Health Inc | Persönliche gesundheitssignalempfänger mit aktiver signalverarbeitung |
MY165532A (en) | 2007-02-01 | 2018-04-02 | Proteus Digital Health Inc | Ingestible event marker systems |
CA2676280C (en) | 2007-02-14 | 2018-05-22 | Proteus Biomedical, Inc. | In-body power source having high surface area electrode |
US8540632B2 (en) | 2007-05-24 | 2013-09-24 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
DK2192946T3 (da) | 2007-09-25 | 2022-11-21 | Otsuka Pharma Co Ltd | Kropsintern anordning med virtuel dipol signalforstærkning |
SG195535A1 (en) | 2008-07-08 | 2013-12-30 | Proteus Digital Health Inc | Ingestible event marker data framework |
KR101214453B1 (ko) * | 2008-08-13 | 2012-12-24 | 프로테우스 디지털 헬스, 인코포레이티드 | 복용 가능한 회로 |
AU2010203625A1 (en) | 2009-01-06 | 2011-07-21 | Proteus Digital Health, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
TWI517050B (zh) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | 供應鏈管理之系統 |
TWI557672B (zh) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置 |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
BR112014001397A2 (pt) | 2011-07-21 | 2017-02-21 | Proteus Biomedical Inc | dispositivo, sistema e método de comunicação móvel |
JP6511439B2 (ja) | 2013-06-04 | 2019-05-15 | プロテウス デジタル ヘルス, インコーポレイテッド | データ収集および転帰の査定のためのシステム、装置、および方法 |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
RU2017123283A (ru) | 2014-12-01 | 2019-01-09 | Пфенекс Инк. | Партнеры по слиянию для получения пептидов |
KR20210018961A (ko) | 2016-07-22 | 2021-02-18 | 프로테우스 디지털 헬스, 인코포레이티드 | 섭취 가능한 이벤트 마커의 전자기 감지 및 검출 |
JPWO2019208724A1 (ja) * | 2018-04-27 | 2021-05-13 | 国立大学法人東北大学 | 所定の化合物に対する膜タンパク質のスクリーニング方法及び所定の化合物の生産方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5989868A (en) * | 1997-09-12 | 1999-11-23 | The Board Of Regents Of The University Of Oklahoma | Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coli |
US6551795B1 (en) * | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
WO2001070776A2 (en) * | 2000-03-10 | 2001-09-27 | Trustees Of Tufts College | Nimr compositions and their methods of use |
WO2001090366A2 (en) * | 2000-05-24 | 2001-11-29 | Curagen Corporation | Human polynucleotides and polypeptides encoded thereby |
WO2006016370A2 (en) | 2004-08-11 | 2006-02-16 | Ramot At Tel Aviv University Ltd. | Soluble fusion proteins comprising heterologous polypeptides |
-
2005
- 2005-08-11 WO PCT/IL2005/000874 patent/WO2006016370A2/en active Application Filing
- 2005-08-11 AT AT05770112T patent/ATE540981T1/de active
- 2005-08-11 EP EP05770112A patent/EP1778729B1/de not_active Not-in-force
-
2007
- 2007-02-12 US US11/705,106 patent/US7560250B2/en not_active Expired - Fee Related
-
2009
- 2009-03-02 US US12/379,808 patent/US7989183B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20070202573A1 (en) | 2007-08-30 |
US7560250B2 (en) | 2009-07-14 |
EP1778729B1 (de) | 2012-01-11 |
EP1778729A2 (de) | 2007-05-02 |
WO2006016370A2 (en) | 2006-02-16 |
US7989183B2 (en) | 2011-08-02 |
US20090226970A1 (en) | 2009-09-10 |
WO2006016370A3 (en) | 2006-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE540981T1 (de) | Lösliche fusionsproteine enthaltend heterologe polypeptide | |
DK1844150T3 (da) | Rekombinant ekspression af proteiner i en to-kædet form med disulfidbroer | |
HRP20200871T1 (hr) | Izmjenjeni rsv f proteini i postupci njihove uporabe | |
CA2443365A1 (en) | Methods for the recombinant production of antifusogenic peptides | |
TW200732472A (en) | Method for the recombinant expression of a polypeptide | |
NZ504548A (en) | Polypeptides and nucleic acids encoding human chordin | |
WO1994018332A3 (en) | Anthrax toxin fusion proteins and uses thereof | |
DE69128285T2 (de) | Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigung | |
WO2003100021A3 (en) | Methods and dna constructs for high yield production of polypeptides | |
WO2010007144A3 (en) | Mutated netrin-4 proteins, fragments thereof and their uses as drugs | |
WO2008105178A1 (ja) | リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム | |
Seeger et al. | The 26S proteasome: a dynamic structure | |
ATE317443T1 (de) | N-terminal verlängerte proteine exprimiert in hefe | |
MXPA05012336A (es) | Procedimiento para producir una proteina dirigida a un plastidio en celulas vegetales. | |
WO2007058267A8 (ja) | 新規タンパク質及びそれをコードする遺伝子 | |
CA2414978A1 (en) | Preparation of a recombinant protein in a prokaryotic host cell | |
AU5776799A (en) | Modified hcv peptide vaccines | |
WO2003100022A3 (en) | Methods and dna constructs for high yield production of polypeptides | |
Montemartini et al. | A recombinant tyrosine aminotransferase from Trypanosoma cruzi has both tyrosine aminotransferase and alanine aminotransferase activities | |
WO2001090382A1 (en) | Fas ligand-fused proteins | |
WO2001090382A3 (fr) | Proteines de fusion agissant en tant que fas-ligand | |
WO2004029209A3 (en) | Epitope-tagged recombinant growth arrest specific gene 6 protein | |
WO2003025182A1 (fr) | Adn de surexpression d'une hormone de croissance et utilisation | |
TR199802168T2 (xx) | IL-16 Aktivitesine sahip işlenmiş polipeptidler, bunları üretmeye mahsus yöntemler ve bunların kullanımı. | |
WO2004056316A8 (en) | Vaccines against hiv-1 tat protein to generate neutralizing antibodies |